Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 9/2010

01-09-2010 | Article

Predicting mortality in patients with community-acquired pneumonia and low CURB-65 scores

Authors: D. Ronan, D. Nathwani, P. Davey, G. Barlow

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2010

Login to get access

Abstract

Some patients classified as having non-severe community-acquired pneumonia (CAP) by CURB-65 subsequently die. The objective of this study was to identify risk factors for mortality in non-severe patients and to test how risk factors might be used. Patients who had a CURB-65 score of 0–2 on admission to hospital and were alive at 30 days were compared with those who died. Identified risk factors were included in new variations of CURB-65 and new management strategies. Age >65 years, blood urea >7 mmol/l, bilateral/multi-lobar appearance of the chest radiograph (CXR), social situation (living alone/no fixed abode or residential/nursing care) and temperature <36°C were associated with mortality (p < 0.05). A two-step approach, with initial use of CURB-65 followed by the above non-CURB-65 criteria, increased the proportion of patients correctly classified as having severe CAP who subsequently died from 54/76 (71%, 95% confidence interval [CI] 61% to 81%) to 72/76 (95%, 95% CI 90% to 100%). The consideration of additional risk factors in a two-step approach can improve the stratification of mortality by CURB-65. Physicians should be cautious about managing patients with CAP as outpatients if they have a CURB-65 score of 1 (or more) and have at least one of the three additional risk factors identified.
Literature
1.
go back to reference British Thoracic Society Standards of Care Committee (2001) BTS guidelines for the management of community acquired pneumonia in adults. Thorax 56(Suppl 4):IV1–IV64 British Thoracic Society Standards of Care Committee (2001) BTS guidelines for the management of community acquired pneumonia in adults. Thorax 56(Suppl 4):IV1–IV64
2.
go back to reference Chalmers JD, Singanayagam A, Hill AT (2008) Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia. Thorax 63:698–702CrossRefPubMed Chalmers JD, Singanayagam A, Hill AT (2008) Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia. Thorax 63:698–702CrossRefPubMed
3.
go back to reference Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58:377–382CrossRefPubMed Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58:377–382CrossRefPubMed
4.
go back to reference Barlow G, Nathwani D, Davey P (2007) The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia. Thorax 62:253–299CrossRefPubMed Barlow G, Nathwani D, Davey P (2007) The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia. Thorax 62:253–299CrossRefPubMed
5.
go back to reference Trotter CL, Stuart JM, George R, Miller E (2008) Increasing hospital admissions for pneumonia, England. Emerg Infect Dis 14(5):727–733CrossRefPubMed Trotter CL, Stuart JM, George R, Miller E (2008) Increasing hospital admissions for pneumonia, England. Emerg Infect Dis 14(5):727–733CrossRefPubMed
6.
go back to reference British Infection Society; British Thoracic Society; Health Protection Agency (2007) Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Provisional guidelines from the British Infection Society, British Thoracic Society, and Health Protection Agency in collaboration with the Department of Health. Thorax 62(Suppl 1):1–46 British Infection Society; British Thoracic Society; Health Protection Agency (2007) Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Provisional guidelines from the British Infection Society, British Thoracic Society, and Health Protection Agency in collaboration with the Department of Health. Thorax 62(Suppl 1):1–46
7.
go back to reference Capelastegui A, España PP, Quintana JM, Areitio I, Gorordo I, Egurrola M, Bilbao A (2006) Validation of a predictive rule for the management of community-acquired pneumonia. Eur Resp J 27:151–157CrossRef Capelastegui A, España PP, Quintana JM, Areitio I, Gorordo I, Egurrola M, Bilbao A (2006) Validation of a predictive rule for the management of community-acquired pneumonia. Eur Resp J 27:151–157CrossRef
8.
go back to reference Man SY, Lee N, Ip M, Antonio GE, Chau SSL, Mak P, Graham CA, Zhang M, Lui G, Chan PKS, Ahuja AT, Hui DS, Sung JJY, Rainer THR (2007) Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong. Thorax 62(4):348–353CrossRefPubMed Man SY, Lee N, Ip M, Antonio GE, Chau SSL, Mak P, Graham CA, Zhang M, Lui G, Chan PKS, Ahuja AT, Hui DS, Sung JJY, Rainer THR (2007) Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong. Thorax 62(4):348–353CrossRefPubMed
9.
10.
go back to reference Nathwani D, Morgan M, Masterton RG, Dryden M, Cookson BD, French G, Lewis D; British Society for Antimicrobial Chemotherapy Working Party on Community-onset MRSA Infections (2008) Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother 61:976–994CrossRefPubMed Nathwani D, Morgan M, Masterton RG, Dryden M, Cookson BD, French G, Lewis D; British Society for Antimicrobial Chemotherapy Working Party on Community-onset MRSA Infections (2008) Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother 61:976–994CrossRefPubMed
11.
go back to reference Barlow G, Nathwani D, Williams F, Ogston S, Winter J, Jones M, Slane P, Myers E, Sullivan F, Stevens N, Duffey R, Lowden K, Davey P (2007) Reducing doorto-antibiotic time in community-acquired pneumonia: controlled before-and-after evaluation and cost-effectiveness analysis. Thorax 62:67–74CrossRefPubMed Barlow G, Nathwani D, Williams F, Ogston S, Winter J, Jones M, Slane P, Myers E, Sullivan F, Stevens N, Duffey R, Lowden K, Davey P (2007) Reducing doorto-antibiotic time in community-acquired pneumonia: controlled before-and-after evaluation and cost-effectiveness analysis. Thorax 62:67–74CrossRefPubMed
12.
go back to reference Challen K, Bright J, Bentley A, Walter D (2007) Physiological-social score (PMEWS) vs. CURB-65 to triage pandemic influenza: a comparative validation study using community-acquired pneumonia as a proxy. BMC Health Serv Res 7:33CrossRefPubMed Challen K, Bright J, Bentley A, Walter D (2007) Physiological-social score (PMEWS) vs. CURB-65 to triage pandemic influenza: a comparative validation study using community-acquired pneumonia as a proxy. BMC Health Serv Res 7:33CrossRefPubMed
13.
go back to reference España PP, Capelastegui A, Gorordo I, Esteban C, Oribe M, Ortega M, Bilbao A, Quintana JM (2006) Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med 174:1249–1256CrossRefPubMed España PP, Capelastegui A, Gorordo I, Esteban C, Oribe M, Ortega M, Bilbao A, Quintana JM (2006) Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med 174:1249–1256CrossRefPubMed
14.
go back to reference Charles PG, Wolfe R, Whitby M, Fine MJ, Fuller AJ, Stirling R, Wright AA, Ramirez JA, Christiansen KJ, Waterer GW, Pierce RJ, Armstrong JG, Korman TM, Holmes P, Obrosky DS, Peyrani P, Johnson B, Hooy M; Australian Community-Acquired Pneumonia Study Collaboration, Grayson ML (2008) SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 47(3):375–384CrossRefPubMed Charles PG, Wolfe R, Whitby M, Fine MJ, Fuller AJ, Stirling R, Wright AA, Ramirez JA, Christiansen KJ, Waterer GW, Pierce RJ, Armstrong JG, Korman TM, Holmes P, Obrosky DS, Peyrani P, Johnson B, Hooy M; Australian Community-Acquired Pneumonia Study Collaboration, Grayson ML (2008) SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 47(3):375–384CrossRefPubMed
15.
go back to reference Cabre M, Serra-Prat M, Palomera E, Almirall J, Pallares R, Clavé P (2010) Prevalence and prognostic implications of dysphagia in elderly patients with pneumonia. Age Ageing 39(1):39–45CrossRefPubMed Cabre M, Serra-Prat M, Palomera E, Almirall J, Pallares R, Clavé P (2010) Prevalence and prognostic implications of dysphagia in elderly patients with pneumonia. Age Ageing 39(1):39–45CrossRefPubMed
16.
go back to reference Mitchell R, Fowkes G, Blane D, Bartley M (2005) High rates of ischaemic heart disease in Scotland are not explained by conventional risk factors. J Epidemiol Community Health 59(7):565–567CrossRefPubMed Mitchell R, Fowkes G, Blane D, Bartley M (2005) High rates of ischaemic heart disease in Scotland are not explained by conventional risk factors. J Epidemiol Community Health 59(7):565–567CrossRefPubMed
Metadata
Title
Predicting mortality in patients with community-acquired pneumonia and low CURB-65 scores
Authors
D. Ronan
D. Nathwani
P. Davey
G. Barlow
Publication date
01-09-2010
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2010
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-010-0970-7

Other articles of this Issue 9/2010

European Journal of Clinical Microbiology & Infectious Diseases 9/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.